XORTX Therapeutics Names Michael Bumby as CFO; U.S.-listed Shares Down 4%

MT NewswiresDec 19 08:21 ET

Correction: -- XORTX Therapeutics Brief: Naming Dr. Michael Bumby, a Biotech/pharma Industry Veteran, as Its Chief Financial Officer Replacing James Fairbairn

MT NewswiresDec 19 07:20 ET

XORTX Therapeutics Brief: Naming Dr. Michael Bumby, a Biotech/pharma Industry Veteran, as Its Chief Financial Officer Replacing James Fairbairn

MT NewswiresDec 19 07:04 ET

XORTX Strengthens Executive Team

GlobeNewswireDec 19 07:00 ET

XORTX Therapeutics Unveils New Kidney Disease Discoveries

TipRanksDec 12 09:37 ET

XORTX Announces Presentation at the Rare and Genetic Disease Summit

GlobeNewswireDec 12 09:17 ET